• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MIRACUM-Pipe:一种适用于下一代测序分析、报告及可视化以支持临床决策的流程。

MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making.

作者信息

Metzger Patrick, Hess Maria Elena, Blaumeiser Andreas, Pauli Thomas, Schipperges Vincent, Mertes Ralf, Christoph Jan, Unberath Philipp, Reimer Niklas, Scheible Raphael, Illert Anna L, Busch Hauke, Andrieux Geoffroy, Boerries Melanie

机构信息

Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.

Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

出版信息

Cancers (Basel). 2023 Jul 1;15(13):3456. doi: 10.3390/cancers15133456.

DOI:10.3390/cancers15133456
PMID:37444566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10340358/
Abstract

(1) Background: Next-generation sequencing (NGS) of patients with advanced tumors is becoming an established method in Molecular Tumor Boards. However, somatic variant detection, interpretation, and report generation, require in-depth knowledge of both bioinformatics and oncology. (2) Methods: MIRACUM-Pipe combines many individual tools into a seamless workflow for comprehensive analyses and annotation of NGS data including quality control, alignment, variant calling, copy number variation estimation, evaluation of complex biomarkers, and RNA fusion detection. (3) Results: MIRACUM-Pipe offers an easy-to-use, one-prompt standardized solution to analyze NGS data, including quality control, variant calling, copy number estimation, annotation, visualization, and report generation. (4) Conclusions: MIRACUM-Pipe, a versatile pipeline for NGS, can be customized according to bioinformatics and clinical needs and to support clinical decision-making with visual processing and interactive reporting.

摘要

(1) 背景:晚期肿瘤患者的下一代测序(NGS)正成为分子肿瘤委员会中的一种既定方法。然而,体细胞变异检测、解读和报告生成需要生物信息学和肿瘤学方面的深入知识。(2) 方法:MIRACUM-Pipe将许多单独的工具整合到一个无缝工作流程中,用于对NGS数据进行全面分析和注释,包括质量控制、比对、变异调用、拷贝数变异估计、复杂生物标志物评估以及RNA融合检测。(3) 结果:MIRACUM-Pipe提供了一个易于使用的、一键式标准化解决方案,用于分析NGS数据,包括质量控制、变异调用、拷贝数估计、注释、可视化和报告生成。(4) 结论:MIRACUM-Pipe是一种通用的NGS流程,可根据生物信息学和临床需求进行定制,并通过可视化处理和交互式报告支持临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/1dc607383353/cancers-15-03456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/5fcfb5e22d91/cancers-15-03456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/f809ca5603e1/cancers-15-03456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/51dfe1f98511/cancers-15-03456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/49ec2b31ce97/cancers-15-03456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/1dc607383353/cancers-15-03456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/5fcfb5e22d91/cancers-15-03456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/f809ca5603e1/cancers-15-03456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/51dfe1f98511/cancers-15-03456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/49ec2b31ce97/cancers-15-03456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05c8/10340358/1dc607383353/cancers-15-03456-g005.jpg

相似文献

1
MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making.MIRACUM-Pipe:一种适用于下一代测序分析、报告及可视化以支持临床决策的流程。
Cancers (Basel). 2023 Jul 1;15(13):3456. doi: 10.3390/cancers15133456.
2
AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.AMLVaran:一种在肿瘤护理环境中对靶向NGS测序数据进行变异分析的软件方法。
BMC Med Genomics. 2020 Feb 4;13(1):17. doi: 10.1186/s12920-020-0668-3.
3
A survey of tools for variant analysis of next-generation genome sequencing data.下一代基因组测序数据变异分析工具综述。
Brief Bioinform. 2014 Mar;15(2):256-78. doi: 10.1093/bib/bbs086. Epub 2013 Jan 21.
4
JWES: a new pipeline for whole genome/exome sequence data processing, management, and gene-variant discovery, annotation, prediction, and genotyping.JWES:一个用于全基因组/外显子组序列数据处理、管理以及基因变异发现、注释、预测和基因分型的新管道。
FEBS Open Bio. 2021 Sep;11(9):2441-2452. doi: 10.1002/2211-5463.13261. Epub 2021 Aug 11.
5
NGS_SNPAnalyzer: a desktop software supporting genome projects by identifying and visualizing sequence variations from next-generation sequencing data.NGS_SNPAnalyzer:一款桌面软件,通过识别和可视化来自下一代测序数据的序列变异,支持基因组项目。
Genes Genomics. 2020 Nov;42(11):1311-1317. doi: 10.1007/s13258-020-00997-7. Epub 2020 Sep 26.
6
Next generation sequence analysis and computational genomics using graphical pipeline workflows.下一代序列分析和使用图形管道工作流的计算基因组学。
Genes (Basel). 2012 Aug 30;3(3):545-75. doi: 10.3390/genes3030545.
7
SEQprocess: a modularized and customizable pipeline framework for NGS processing in R package.SEQprocess:一个用于 R 包中 NGS 处理的模块化和可定制的管道框架。
BMC Bioinformatics. 2019 Feb 20;20(1):90. doi: 10.1186/s12859-019-2676-x.
8
Performance evaluation of pipelines for mapping, variant calling and interval padding, for the analysis of NGS germline panels.用于分析NGS种系基因检测板的映射、变异位点检测和区间填充流程的性能评估。
BMC Bioinformatics. 2021 Apr 28;22(1):218. doi: 10.1186/s12859-021-04144-1.
9
ToTem: a tool for variant calling pipeline optimization.ToTem:一种用于变异调用管道优化的工具。
BMC Bioinformatics. 2018 Jun 26;19(1):243. doi: 10.1186/s12859-018-2227-x.
10
CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.CSN和CAVA:用于临床环境中快速、可靠的下一代测序分析的变异注释工具。
Genome Med. 2015 Jul 28;7(1):76. doi: 10.1186/s13073-015-0195-6.

引用本文的文献

1
Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy.通过分子成像、纵向多部位采样以及对接受生长抑素受体导向放射性药物治疗的晚期小细胞肺癌进行尸检检查进行综合表征。
J Nucl Med. 2025 Feb 3;66(2):245-249. doi: 10.2967/jnumed.124.268513.
2
Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards.助力个性化肿瘤学:分子肿瘤委员会数字支持与可视化工具的发展
BMC Med Inform Decis Mak. 2025 Jan 16;25(1):29. doi: 10.1186/s12911-024-02821-8.
3

本文引用的文献

1
DNAscan2: a versatile, scalable, and user-friendly analysis pipeline for human next-generation sequencing data.DNAscan2:一种功能多样、可扩展且易于使用的人类下一代测序数据分析管道。
Bioinformatics. 2023 Apr 3;39(4). doi: 10.1093/bioinformatics/btad152.
2
iCOMIC: a graphical interface-driven bioinformatics pipeline for analyzing cancer omics data.iCOMIC:一个由图形界面驱动的用于分析癌症组学数据的生物信息学流程。
NAR Genom Bioinform. 2022 Jul 25;4(3):lqac053. doi: 10.1093/nargab/lqac053. eCollection 2022 Sep.
3
Searching of Clinical Trials Made Easier in cBioPortal Using Patients' Genetic and Clinical Profiles.
Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study.
全外显子组测序、突变特征分析与多发性骨髓瘤的预后——一项试点研究
Int J Mol Sci. 2024 Dec 14;25(24):13418. doi: 10.3390/ijms252413418.
4
Unveiling the Digital Evolution of Molecular Tumor Boards.揭示分子肿瘤委员会的数字化演变
Target Oncol. 2025 Jan;20(1):27-43. doi: 10.1007/s11523-024-01109-1. Epub 2024 Nov 28.
5
Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium.评估和提高电子健康记录数据的适用性:大学医学联合会研究与护理医学信息学中当前实践及自动化方法途径的定性研究
JMIR Med Inform. 2024 Aug 19;12:e57153. doi: 10.2196/57153.
6
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.原发性中枢神经系统肿瘤患者的综合基因分析及分子靶向治疗
NPJ Precis Oncol. 2024 Aug 14;8(1):180. doi: 10.1038/s41698-024-00674-y.
7
Uncovering Harmonization Potential in Health Care Data Through Iterative Refinement of Fast Healthcare Interoperability Resources Profiles Based on Retrospective Discrepancy Analysis: Case Study.基于回顾性差异分析,通过快速医疗保健互操作性资源概况的迭代优化来挖掘医疗保健数据中的协调潜力:案例研究
JMIR Med Inform. 2024 Jul 23;12:e57005. doi: 10.2196/57005.
8
[The Medical Informatics Initiative at a glance-establishing a health research data infrastructure in Germany].[德国医学信息学倡议概览——建立健康研究数据基础设施]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Jun;67(6):616-628. doi: 10.1007/s00103-024-03887-5. Epub 2024 Jun 5.
9
[The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)].作为医学信息学计划(MII)一部分的“肿瘤个性化医疗”(PM4Onco)合作项目。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Jun;67(6):668-675. doi: 10.1007/s00103-024-03886-6. Epub 2024 May 13.
10
[Personalized medicine in oncology].[肿瘤学中的个性化医疗]
Pathologie (Heidelb). 2024 May;45(3):180-189. doi: 10.1007/s00292-024-01315-8. Epub 2024 Apr 3.
利用 cBioPortal 中的患者遗传和临床资料,更轻松地搜索临床试验。
Appl Clin Inform. 2022 Mar;13(2):363-369. doi: 10.1055/s-0042-1743560. Epub 2022 Mar 30.
4
Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer.基因组 nexus:癌症基因组变异注释和解读的综合资源
JCO Clin Cancer Inform. 2022 Feb;6:e2100144. doi: 10.1200/CCI.21.00144.
5
cbpManager: a web application to streamline the integration of clinical and genomic data in cBioPortal to support the Molecular Tumor Board.cbpManager:一个简化 cBioPortal 中临床和基因组数据集成的 Web 应用程序,以支持分子肿瘤委员会。
BMC Med Inform Decis Mak. 2021 Dec 20;21(1):358. doi: 10.1186/s12911-021-01719-z.
6
Challenges and Experiences Extending the cBioPortal for Cancer Genomics to a Molecular Tumor Board Platform.将 cBioPortal 癌症基因组学扩展到分子肿瘤委员会平台所面临的挑战和经验。
Stud Health Technol Inform. 2021 Nov 18;287:139-143. doi: 10.3233/SHTI210833.
7
JWES: a new pipeline for whole genome/exome sequence data processing, management, and gene-variant discovery, annotation, prediction, and genotyping.JWES:一个用于全基因组/外显子组序列数据处理、管理以及基因变异发现、注释、预测和基因分型的新管道。
FEBS Open Bio. 2021 Sep;11(9):2441-2452. doi: 10.1002/2211-5463.13261. Epub 2021 Aug 11.
8
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients.少样本学习创建了药物反应的预测模型,这些模型可以从高通量筛选转化到个体患者身上。
Nat Cancer. 2021 Feb;2(2):233-244. doi: 10.1038/s43018-020-00169-2. Epub 2021 Jan 25.
9
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.综合基因组学和转录组学分析指导罕见癌症患者的治疗决策。
Cancer Discov. 2021 Nov;11(11):2780-2795. doi: 10.1158/2159-8290.CD-21-0126. Epub 2021 Jun 10.
10
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany.欧洲开拓性的精准医学:瑞典基因组医学和德国个体化医疗中心(ZPM)的联合观点。
Semin Cancer Biol. 2022 Sep;84:242-254. doi: 10.1016/j.semcancer.2021.05.026. Epub 2021 May 24.